June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Safety and Efficacy of Phacorrefractive Surgery in a Middle Age Hispanic Population
Author Affiliations & Notes
  • Jose Alberto Nava
    Instituto de Oftalmologia - Catarata, Centro Medico Zambrano Hellion - Tec de Monterrey, San Pedro Garza Garcia, Mexico
  • Footnotes
    Commercial Relationships Jose Nava, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 681. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jose Alberto Nava; Safety and Efficacy of Phacorrefractive Surgery in a Middle Age Hispanic Population. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):681.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To analyze the outcomes (safety and efficacy) of phacorrefractive surgery (Clear Lens Extraction) in a Hispanic population and its correlation to age and axial length

Methods: We selected a random sample of 500 files from patients 35 years to 55 years old who underwent phacoemulsification during the years 2009 to 2012 in an ophthalmology service in Monterrey Mexico. 40 cases of Clear Lens Extraction were performed. Change in visual acuity, type of IOL, use of YAG laser and complications were evaluated

Results: 40 cases were analyzed and followed. No cases of retinal detachment were found and improvement of visual acuity in all cases was observed. We observed 3 cases of PCO, all of them in the longest axial lengths. Comorbidities, IOL types and bio measures are described

Conclusions: Increase availability of multifocal lenses has increased phacorrefractive procedures in younger patients without cataracts. Despite our results, safety and efficacy of this procedure in young adults is still to be determined

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×